EpiMonitor

Next-Gen Epilepsy Monitoring

Available in the US, UK, EU, AU, NZ and CA

Embrace2

Embrace2

Peace of Mind

No longer available for purchase

Empatica Logo
  • Solutions

    Empatica Health Monitoring Platform

    Empatica Health Monitoring Platform

    One platform, multiple applications

    Components

    EmbracePlus wearable
    EmbraceMini wearable
    New
    Care software suite
    eCOA
    Digital biomarkers
    Cloud API for Clinical Trials

    Use Cases

    Clinical Trials
    Designed for the patient, enhanced for the scientist
    Actigraphy
    The new standard to measure sleep and physical activity
    Contract Research Organizations
    Enhanced value and effortless integrations for CROs
    Parkinson's Monitoring
    New
    Improve patient outcomes with validated PKG measures
    Academic Research
    Unlock the future of real-world research
    Go to store
  • Scientific Evidence

    Publications
    Scientific publications using our technology
    Case Studies
    Client success stories
  • Resources

    Compliance
    Global regulatory requirements
    Blog
    Thoughts and news
    Digital resources library
    Online and downloadable resources
    Support center
    Get support with our products
  • Company

    About us
    People with purpose
    Careers
    Join the mission
    Contact us
    Talk to our team
Contact Us
Empatica Logo
Empatica Health Monitoring Platform

Empatica Health Monitoring Platform

One platform, multiple applications

Components

EmbracePlus wearable
EmbraceMini wearable
New
Care software suite
eCOA
Digital biomarkers
Cloud API for Clinical Trials

Use Cases

Clinical Trials
Designed for the patient, enhanced for the scientist
Actigraphy
The new standard to measure sleep and physical activity
Contract Research Organizations
Enhanced value and effortless integrations for CROs
Parkinson's Monitoring
New
Improve patient outcomes with validated PKG measures
Academic Research
Unlock the future of real-world research
Go to store
Publications
Scientific publications using our technology
Case Studies
Client success stories
Compliance
Global regulatory requirements
Blog
Thoughts and news
Digital resources library
Online and downloadable resources
Support center
Get support with our products
About us
People with purpose
Careers
Join the mission
Contact us
Talk to our team
EpiMonitor

Next-Gen Epilepsy Monitoring

Available in the US, UK, EU, AU, NZ and CA

Embrace2
Embrace2

Peace of Mind

No longer available for purchase

Contact Us
News

Empatica's technology heads to Antarctica in human metabolism study

Empatica

Empatica

Jan 2, 2023• 4 min read

LinkedinFacebookX

The South Pole is one of the most demanding environments on the planet. The average annual temperature at the South Pole is -50°C, while the average altitude across Antarctica is 2,400m and can go above 4,000m. High altitudes can lead to hypoxia, while some of the other physical threats of polar travel include dehydration, hypothermia, snow blindness, frostbite, and altitude sickness.

Since 1911, when Norwegian explorer Roal Amundsen first successfully reached the South Pole, many Antarctic expeditions have taken place, though only a handful of missions were undertaken for medical research purposes. As a company dedicated to improving medical and scientific research and enabling new discoveries, Empatica is proud to provide its technology to yet another innovative project.

INSPIRE 22 is a unique and ambitious medical research expedition, aiming to study the metabolic cost of sustained polar travel. The challenge of reaching the South Pole is not only physical, but also mental and nutritional. By studying changes in energy metabolism and food utilization in a harsh environment and while undergoing intense physical exertion, scientists will be able to study how the body adapts to and copes with extreme cold, and also the kind of nutrition necessary to minimize metabolic changes.

The eventual findings of this work can not only help scientists understand how we can survive sudden changes to our environment and monitor health during future exploration missions, but also have immense translational implications for patients, by providing new approaches to managing diseases and their treatments and supporting disaster relief.

The INSPIRE 22 team has previously studied the impact of polar travel on metabolism in labs, before and after expeditions. With the help of wearable technology, the research team can now also continuously monitor changes in the physiology of the team members while they are skiing across Antarctica to reach the South Pole. Members of the expedition are wearing an EmbracePlus to continuously measure their health data, which will then be analyzed to understand the effects of extreme environments on human metabolism, as well as the potential impact of wearable technology in measuring health in such environments, by studying changes in metabolic and inflammatory biomarkers.

“Participants will be monitored using wearable technology while in Antarctica. Unanswered research questions remain: what physiological or biochemical signal should be measured?; what is the physiological normal when people are working hard in remote environments? This collaborative endeavour aims to investigate the potential opportunities that wearable technology can offer to explore these questions.” (from the INSPIRE 22 website)

The study is also providing answers to other questions, such as ‘How far can research and telemedicine go?’ ‘What if health data could be collected and streamed from anywhere in the world (or even Mars)?’ EmbracePlus, funded to work in space, has been engineered to be durable and reliable, even in the most austere of environments, opening up the opportunity for research to take place in previously unthought-of conditions and locations.

The first tri-service team set off from the Messner Start in November, and will be covering a total distance of 900 km. They are now being joined by a civilian team, including Empatica’s General Manager, Ivan Cenci, as they ski the Last Degree to reach the South Pole. Follow @empatica and @Inspire22 for frequent updates on the mission.

Company
About us
Careers
Legal
Blog
Empatica Health Monitoring Platform
Clinical Trials
Academic Research
Actigraphy
Parkinson's Monitoring
Parkinson’s & Movement Disorders
Log in
Care Portal
Care Lab Portal
Research Portal
Epilepsy Monitoring
EpiMonitor
Embrace2
Get Support
Contact Us
Manuals
Empatica
FacebookInstagramYouTubeTwitterLinkedin

Empatica Inc., 1 Broadway, 14th floor, Cambridge MA 02142 United States - Empatica Srl, Via Stendhal 36, 20144 Milano (MI), Italy

P. IVA IT07462810966. Copyright © 2026 Empatica Inc. - ISO 13485 Cert. No. 39050072201 - All rights reserved - Legal